Compare Merck & Company (6MK) vs. Competitors

0 Followers

Comparison Results

6MK

Merck & Company

CHF96.58

CHF291.42B

113.33

0.00%

14 Buy

7 Hold

0 Sell

Moderate Buy

Bristol-Myers Squibb

$64.72

$121.73B

13.15

33.68%

8 Buy

12 Hold

1 Sell

Moderate Buy

Johnson & Johnson

$273.14

$613.99B

29.88

36.83%

14 Buy

4 Hold

0 Sell

Strong Buy

Novartis

$159.98

$257.77B

21.87

8.92%

3 Buy

3 Hold

1 Sell

Moderate Buy

Pfizer

$28.57

$156.74B

37.00

6.59%

7 Buy

14 Hold

1 Sell

Moderate Buy

AbbVie

$265.79

$471.27B

76.45

16.55%

20 Buy

4 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

6MK vs ABBV

xxxxxxxxxxxxx

Performance Comparison

CH:6MK

Merck & Company

96.58

0.00

0.00%

BMY

Bristol-Myers Squibb

59.70

17.06

40.00%

JNJ

Johnson & Johnson

258.45

72.94

39.32%

NVS

Novartis

143.28

13.51

10.41%

PFE

Pfizer

28.00

4.00

16.68%

ABBV

AbbVie

271.36

47.08

20.99%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >